The Open Markets submitted a comment letter calling for aggressive action, including the use of tariff and quotas, to diversify U.S. supply chains.
Read MoreOpen Markets Industrial Policy Program Manager Audrey Stienon penned a piece in The American Prospect on the pros and cons of California’s close partnership with Civica Rx, as the state begins to manufacture insulin in an effort to lower costs.
Read MoreIn this issue, we explore how private equity titans have set their sights on the care economy, deploying classic rollup strategies to limit competition and raise prices. We also launch two new papers on the Robinson-Patman Act (RPA) making the case for the U.S. government to revive enforcement of the RPA in order to help build a fairer, more open, and more decentralized economy.
Read MoreIn this issue, we look at our conference detailing Facebook’s attacks on the free press, featuring a keynote by Senator Klobuchar. And we explore California’s subsidized manufacture of insulin.
Read MoreIn this issue, we take a look at how electric vehicle manufacturers’ move into the lithium business could lead to a lithium shortage, shortchanging sectors like solar and wind.
Read MoreIn this issue, we look at U.S. Trade Rep Katherine Tai’s new vision for trade, which she detailed in a groundbreaking speech hosted by Open Markets.
Read More